CEACAM5 Antikörper
(1 reference)Kurzübersicht für CEACAM5 Antikörper (ABIN2472309)
Target
Alle CEACAM5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Isotyp
- IgG1
-
-
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibody
CEACAM5 Reaktivität: Human WB, IHC, IP Wirt: Maus Monoclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human FACS, IHC (p), IHC (fro), IP Wirt: Maus Monoclonal CB30 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) (AA 50-77), (N-Term) antibodyCEACAM5 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB18886 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) (AA 35-165) antibodyCEACAM5 Reaktivität: Human FACS, ELISA Wirt: Maus Monoclonal 3B9C9 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human FACS, IF, IHC (f) Wirt: Maus Monoclonal CEA31 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human FACS, WB, ELISA, IHC (fro), cELISA Wirt: Maus Monoclonal 26-3-13 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) (AA 1-255) antibodyCEACAM5 Reaktivität: Human IF, WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human IHC, ELISA Wirt: Maus Monoclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) (Internal Region) antibodyCEACAM5 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human IF, WB, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principle." in: Journal of immunological methods, Vol. 275, Issue 1-2, pp. 99-112, (2003) (PubMed).
-
: "Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principle." in: Journal of immunological methods, Vol. 275, Issue 1-2, pp. 99-112, (2003) (PubMed).
-
- CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5))
-
Andere Bezeichnung
- CD66e
-
Hintergrund
- Synonyms: CEA
-
Gen-ID
- 1048
-
UniProt
- P06731
Target
-
